Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Quest Diagnostics To Host Investor Day On November 11, 2016

Quest Diagnostics
Posted on: 29 Sep 16

MADISON, N.J., Sept. 27, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Friday, November 11, 2016 at The Intercontinental New York Barclay Hotel, 111 East 48th St, New York, NY. 

During the event, President and Chief Executive Officer Steve Rusckowski, Chief Financial Officer Mark Guinan, and other senior executives will share progress made on implementing the company's strategy, including key growth initiatives and opportunities to drive operational excellence, as well as provide updated views of the market. 

Advance registration is required for those planning to attend in person. To register for the event, please go to the following website:

A live webcast of the event will be broadcast on the Investor Relations page of the Quest Diagnostics website.  Additional information on accessing the webcast will be provided at a future date.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 44,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Quest, Quest Diagnostics, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks are the property of their respective owners.

Shawn Bevec (Investors): 973-520-2900 
Dennis Moynihan (Media): 973-520-2800    

For more information:

Editor's Details

Mike Wood

Last updated on: 29/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.